Form 8-K - Current report:
SEC Accession No. 0001641172-25-016126
Filing Date
2025-06-23
Accepted
2025-06-23 17:06:41
Documents
13
Period of Report
2025-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 51913
  Complete submission text file 0001641172-25-016126.txt   265298

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tvgn-20250623.xsd EX-101.SCH 3814
3 XBRL DEFINITION FILE tvgn-20250623_def.xml EX-101.DEF 26690
4 XBRL LABEL FILE tvgn-20250623_lab.xml EX-101.LAB 36843
5 XBRL PRESENTATION FILE tvgn-20250623_pre.xml EX-101.PRE 25314
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5982
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41002 | Film No.: 251065781
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)